Japan Intellectual Property Rights: FORMULATIONS/COMPOSITIONS COMPRISING BTK INHIBITOR

Japan, July 6 -- JANSSEN PHARMACEUTICA NV has got intellectual property rights for 'FORMULATIONS/COMPOSITIONS COMPRISING BTK INHIBITOR.' Other related details are as follows:

Application Number: JP,2023-183050

Category (FI): A61K47/32,A61P43/00,111,A61P29/00,A61P19/10,A61P43/00,105,A61P35/02,A61P35/00,A61P37/02,A61P29/00,101,A61P19/02,A61K47/12,A61K47/04,A61K47/20,A61K9/20,A61K47/38,A61K31/519

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 25, 2023

Publication Date: Feb. 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....